TABLE 2.
Donor type | Number | Cutoff (×106/L for XN-HPCs and CD34 cells | XN-HPC |
CD34 |
||
---|---|---|---|---|---|---|
PPV (%) | NPV (%) | PPV (%) | NPV (%) | |||
All | 107 | 38* | 71.4 | 97.7 | 78.9 | 98.0 |
Autologous | 99 | 68.4 | 100 | 76.5 | 100 | |
Allogeneic | 8 | 100 | 50 | 100 | 50 | |
All | 107 | 20† | 55.4 | 100 | 63.0 | 100 |
Autologous | 99 | 52.0 | 100 | 59.1 | 100 | |
Allogeneic | 8 | 87.5 | ‡ | 100 | 100 | |
All | 107 | 15 | 50.0 | 100 | 57.5 | 100 |
Autologous | 99 | 46.4 | 100 | 54.2 | 100 | |
Allogeneic | 8 | 87.5 | ‡ | 87.5 | ‡ | |
All | 107 | 10 | 45.1 | 100 | 51.7 | 100 |
Autologous | 99 | 41.5 | 100 | 48.1 | 100 | |
Allogeneic | 8 | 87.5 | ‡ | 87.5 | ‡ | |
All | 107 | 5 | 44.2 | 100 | 44.2 | 100 |
Autologous | 99 | 40.6 | 100 | 40.6 | 100 | |
Allogeneic | 8 | 87.5 | ‡ | 87.5 | ‡ |
Cutoff derived from ROC analysis.
Cutoff based on Armitage et al.14
Unable to calculated NPV due to absence of true-negative population.